Chemkart India Limited appointed M/s Prem Chand Jain & Co., Chartered Accountants, as its statutory auditors for a five-year term covering financial years 2026-27 through 2030-31. The Board of Directors approved the appointment on August 18, 2026, pending ratification by shareholders at the company’s 7th Annual General Meeting (AGM).

The firm, which holds Firm Registration Number (FRN) 000066C, will hold office from the conclusion of the 7th AGM until the conclusion of the 12th AGM in 2031. Established over 57 years ago, Prem Chand Jain & Co. operates with a head office in Mumbai and branch offices in Indore, Pune, Bhopal, and Ahmedabad. The firm serves leading banking institutions, multinational companies, and corporate clients, offering expertise in statutory audits, internal audits, tax advisory, risk advisory, and regulatory compliance.

Secretarial Audit Appointment

In a parallel move, the board appointed M/s Nirmal Tiwari & Associates, Company Secretaries, as the secretarial auditor for the same five-year period (FY27 to FY31). This appointment is also subject to shareholder approval at the ensuing 7th AGM.

M/s Nirmal Tiwari & Associates, registered with the Institute of Company Secretaries of India (ICSI) under Membership Number F11031 and Certificate of Practice 25159, specializes in company law compliance, SEBI listing compliance, and secretarial audit services. The firm is located in Malad West, Mumbai.

Regulatory Disclosures

The company disclosed that neither the statutory nor the secretarial auditors are related to any directors of Chemkart India Limited. The appointments align with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

7th Annual General Meeting

The board scheduled the 7th AGM for September 19, 2026, at 12:00 pm via video conferencing or other audio-visual means. The meeting will address the financial year ended March 31, 2026, and include the approval of the auditor appointments.

CS Nirmal Tiwari, proprietor of Nirmal Tiwari & Associates, was appointed as the scrutinizer to oversee the voting process. The company will issue separate intimation regarding the notice, record date, book closure date, and e-voting period.

Chemkart India Limited company name has completed a ₹1.00 crore investment in its wholly owned subsidiary, Easy Raw Materials Private Limited, through a rights issue. The transaction involves the allotment of 10,00,000 equity shares at an issue price of ₹10 each, which is equal to the face value. This capital injection is designated for the commissioning of the subsidiary’s manufacturing unit, adhering to the objects of the initial public offer prospectus dated July 10, 2025.

The disclosure was made to the Bombay Stock Exchange on August 8, 2026, under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing cites Regulation 30(6) read with Schedule III Part A Para A (1) of the SEBI LODR Regulations, as amended. Additionally, the company referenced circular SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, regarding the required details of the transaction.

Transaction Details

The investment was executed via cash consideration. Chemkart India acquired 10,00,000 equity shares with a face value of ₹10 each. The total consideration paid was ₹1.00 crore. As Easy Raw Materials Private Limited is a wholly owned subsidiary, the pre-allotment shareholding of Chemkart India was 100.00%, and it remains 100.00% post-allotment. The transaction is classified as a related party transaction but was conducted at arm’s length. No governmental or regulatory approvals were required for this acquisition.

Subsidiary Financial Position

Easy Raw Materials Private Limited, incorporated in 2020, operates in the trading of pharma products and nutritional supplements. The subsidiary’s authorized share capital stands at ₹10,00,00,000, divided into 1,00,00,000 equity shares of ₹10 each. Following the recent allotment, the paid-up share capital is ₹8,51,00,000, comprising 85,10,000 equity shares.

As of March 31, 2026, the subsidiary reported a turnover of NIL. It recorded a loss after tax of ₹59.47 lakhs and a net worth of ₹578.60 lakhs. The turnover for the last three years has been NIL, indicating that the entity is in the pre-revenue phase ahead of the manufacturing unit commissioning funded by this investment.